Healthcare provider profile · identity verified

Mary Leta Collins, NP

Nurse Practitioner · COOKEVILLE, TN · NPI 1396830998

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	289	91
Levothyroxine Sodium	Levothyroxine Sodium	246	65
Omeprazole	Omeprazole	246	85
Losartan Potassium	Losartan Potassium	234	67
Amlodipine Besylate	Amlodipine Besylate	220	66
Lisinopril	Lisinopril	177	48
Rosuvastatin Calcium	Rosuvastatin Calcium	158	47
Gabapentin	Gabapentin	131	28
Fluticasone Propionate	Fluticasone Propionate	129	60
Albuterol Sulfate Hfa	Albuterol Sulfate	125	45
Metoprolol Succinate	Metoprolol Succinate	114	39
Pantoprazole Sodium	Pantoprazole Sodium	104	28
Metformin Hcl Er	Metformin Hcl	101	30
Alendronate Sodium	Alendronate Sodium	97	27
Alprazolam	Alprazolam	92	18
Duloxetine Hcl	Duloxetine Hcl	91	22
Trazodone Hcl	Trazodone Hcl	89	33
Furosemide	Furosemide	88	26
Prednisone	Prednisone	88	59
Glipizide Er	Glipizide	85	20
Ezetimibe	Ezetimibe	83	32
Tramadol Hcl	Tramadol Hcl	83	22
Hydrochlorothiazide	Hydrochlorothiazide	79	27
Metformin Hcl	Metformin Hcl	78	21
Simvastatin	Simvastatin	78	22
Meloxicam	Meloxicam	76	31
Tizanidine Hcl	Tizanidine Hcl	73	26
Montelukast Sodium	Montelukast Sodium	72	26
Farxiga	Dapagliflozin Propanediol	70	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	20
Pravastatin Sodium	Pravastatin Sodium	70	22
Escitalopram Oxalate	Escitalopram Oxalate	64	24
Famotidine	Famotidine	64	23
Metoprolol Tartrate	Metoprolol Tartrate	54	20
Fluoxetine Hcl	Fluoxetine Hcl	51	19
Ozempic	Semaglutide	49	12
Diclofenac Sodium	Diclofenac Sodium	47	20
Mounjaro	Tirzepatide	47	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	47	13
Tamsulosin Hcl	Tamsulosin Hcl	44	13
Allopurinol	Allopurinol	42	13
Carvedilol	Carvedilol	42	13
Chlorthalidone	Chlorthalidone	41	12
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	41	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Cefdinir	Cefdinir	38	30
Spironolactone	Spironolactone	38	13
Atenolol	Atenolol	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	15
Estradiol	Estradiol	37	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Jardiance	Empagliflozin	34	13
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Azelastine Hcl	Azelastine Hcl	33	18
Potassium Chloride	Potassium Chloride	33	13
Clopidogrel	Clopidogrel Bisulfate	31	11
Fluconazole	Fluconazole	31	23
Hydroxyzine Hcl	Hydroxyzine Hcl	31	11
Telmisartan	Telmisartan	31	suppressed
Lovastatin	Lovastatin	30	suppressed
Azithromycin	Azithromycin	27	26
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	18
Methylprednisolone	Methylprednisolone	26	20
Ondansetron Odt	Ondansetron	26	19
Eliquis	Apixaban	25	11
Triamcinolone Acetonide	Triamcinolone Acetonide	25	20
Buspirone Hcl	Buspirone Hcl	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	11
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Nystatin	Nystatin	21	14
Promethazine Hcl	Promethazine Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	16
Synthroid	Levothyroxine Sodium	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	12
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Mupirocin	Mupirocin	15	11
Clonidine	Clonidine	14	suppressed
Linzess	Linaclotide	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Lorazepam	Lorazepam	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Finasteride	Finasteride	11	suppressed
Indapamide	Indapamide	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error